Fumio Nishikaku

Director/Board Member at HuLA immune, Inc.

Health Technology

Commercial Services

Profile

Fumio Nishikaku currently works at MATRIXOME, Inc., as Director and HuLA immune, Inc., as Director.

Companies	Position	Start
HuLA immune, Inc. HuLA immune, Inc. Pharmaceuticals: MajorHealth Technology HuLA immune, Inc. is a Japanese company that provides immune cell therapy for cancer treatment. The company is based in Tokyo, Japan. The text in the company's description appears to be a mix of non-English languages, including British English and Japanese. It was founded in 2017 and the CEO is Yasuhiro Shindo.	Director/Board Member	-
MATRIXOME, Inc. MATRIXOME, Inc. Miscellaneous Commercial ServicesCommercial Services MATRIXOME, Inc. is a Japanese regenerative medicine company founded in 2015. The company is based in Osaka, Japan and develops regenerative medicine using laminin E8 fragment technology.	Director/Board Member	-

Active

Inactive

Listed companies

Private companies

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

Private companies	2
HuLA immune, Inc. HuLA immune, Inc. Pharmaceuticals: MajorHealth Technology HuLA immune, Inc. is a Japanese company that provides immune cell therapy for cancer treatment. The company is based in Tokyo, Japan. The text in the company's description appears to be a mix of non-English languages, including British English and Japanese. It was founded in 2017 and the CEO is Yasuhiro Shindo.	Health Technology
MATRIXOME, Inc. MATRIXOME, Inc. Miscellaneous Commercial ServicesCommercial Services MATRIXOME, Inc. is a Japanese regenerative medicine company founded in 2015. The company is based in Osaka, Japan and develops regenerative medicine using laminin E8 fragment technology.	Commercial Services